Advisory Board memebers

---

Dr. Kumar is a distinguished expert in biomedical engineering, tissue engineering, biosensors, nanomedicine, and regenerative medicine, with over 15 years of experience in bio-material and clinical research. His contributions to these fields have been instrumental in advancing the development of innovative solutions for tissue repair and regeneration, as well as the design of cutting-edge biomedical technologies. Dr. Kumar's expertise and experience make him internationally known and a highly respected professional, driving progress and innovation in the field of biomedical engineering and regenerative medicine.

Dr. Pandit possesses extensive expertise in the areas of biomarker studies, assay development, precision medicine, and product development. With over 20 years of experience in these domains, Dr. Pandit's profound knowledge and skillset are invaluable for providing crucial insights into the design of immunological response studies related to bone grafts, as well as guiding the entire development process. His profound expertise and extensive experience make him an esteemed professional capable of making significant contributions in advancing research and development efforts in this field.

Mr. Dixit is a highly skilled professional with expertise in business development, operations, and collaboration. His exceptional ability to foster strategic partnerships and leverage synergies enables the creation of new opportunities for business expansion. With a keen understanding of industry trends and market dynamics, he proactively identifies untapped market potentials and develops innovative strategies to capitalize on them. His valuable contributions make him an invaluable asset in driving organizational growth and achieving sustained success in a competitive business environment. 

Ms. Inês Salvador has remarkable ideas and concepts in the realm of biomedical device development. Within a single year, she has gained a deep comprehension of the field and the ability to transform innovative concepts into pioneering products. Her consistent success and unwavering dedication to innovation mark her as an essential contributor, poised to advance the evolution of cutting-edge solutions in the development of biomedical devices.

Ms. Caitlin Blades is a highly accomplished professional known for her exceptional proficiency in formulating and refining product ideas and concepts. With an impressive eight-year tenure collaborating closely with prominent biotech companies, she has cultivated a deep understanding of the intricacies of the industry. Ms. Blades' extensive experience equips her with the expertise to envision and develop groundbreaking product concepts that have the potential to revolutionize the biotech landscape. Her track record of success and unwavering commitment to innovation positions her as an indispensable asset, poised to drive the advancement of cutting-edge solutions within the biotech sector. 

Dr. Blough brings to the table a vast and diverse background of more than 20 years, primarily focused on conducting meticulous cellular studies using cultured cells. Their extensive experience encompasses a wide range of essential techniques, including proficiently executing fluorescent microscopy experiments, undertaking comprehensive bio-compatibility studies, and conducting thorough toxicological assessments of various chemical agents. Moreover, Dr. Blough's expertise extends to conducting such investigations not only within cell culture systems but also within animal models, thereby providing a comprehensive understanding of the biological implications and potential risks associated with these agents. 

Janet L. Dally brings over 20 years of experience in the biotechnology, pharmaceutical, and medical technology industries. Her diverse background encompasses roles as an investor relations advisor, healthcare fund analyst, business development specialist, medical device marketing manager, and microbiologist. Since 2010, she has organized a prestigious annual cancer immunotherapy conference for the investment community and industry stakeholders, solidifying her position as a respected leader in the field. 

Mr. Thornley has accumulated over 30 years of valuable experience within the cosmetic and chemical industries, as well as in business development and operations. Having held senior-level positions in corporate settings, he has consistently demonstrated proficiency in sales and finance. His instrumental contributions in product launches underline his expertise and strategic acumen. As a respected member of the team, Mr. Thornley's guidance will prove invaluable, particularly in the realms of sales network development and financial considerations.